Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Opioid Use Disorder (OUD)
- 1.00 AMA P...See more
$0.00
This lecture is designed to address:Evidence that treatment worksConsequences of InactionOvercoming barriers to evidence based care Research Testing Innovative Solutions
- Buprenorph...See more
- 1.00 AMA P...See more
$0.00
This talk will describe the distribution of buprenorphine patient caseloads for clinicians prescribing formulations of buprenorphine indicated to treat opioid use disorder, how those caseloads evolve over time, and factors associated higher-volume buprenorphine prescribers. The presentation will also discuss implications for expanding access to medication treatment for opioid use disorder and state and federal policy efforts.
- DepressionSee more
- 1.00 AMA P...See more
$0.00
This lecture will review the prevalence and challenges in managing patients with co-occurring opioid use disorder, depression and self-injurious behavior.
- Opioid Use Disorder (OUD)
- 1.00 AMA P...See more
$0.00
This lecture will review current data on opioid use in youth. Treatment strategies including medication management, behavioral interventions, and harm reduction approaches will be discussed.
- Pharmacolo...See more
- 3.00 AMA P...See more
$0.00
Podcast seriesSCOPE of Pain is a series of continuing education activities designed to help you safely and effectively manage patients with acute and/or chronic pain, when appropriate, with opioid analgesics. Through the case of Michelle Jones, a 36-year-old who has a displaced right femoral neck fracture due to a motor vehicle crash, you'll learn how to:
- Prescribin...See more
- 4.00 AMA PRA Category 1 Credit™
$0.00
As part of ongoing efforts to address the epidemic of opioid overdose deaths, New York State has established educational requirements to raise healthcare provider awareness of the risks associated with prescribing and taking opioid pain medications. This program fulfills the mandate by providing education about state and federal requirements for prescribing controlled substances; pain management; appropriate prescribing; managing acute pain; palliative medicine; prevention, screening and signs of addiction; responses to abuse and addiction; and end of life care.
- Drug Diver...See more
- 3.50 AMA PRA Category 1 Credit™
$0.00
The Colorado Consortium for Prescription Drug Abuse Prevention coordinates Colorado’s response to the misuse of medications such as opioids, stimulants, and sedatives. The Consortium’s mission is to reduce prescription drug misuse and abuse in Colorado by developing policies, programs, and partnerships with the many state agencies, organizations, and community coalitions addressing one of Colorado’s major public health crises.
- Mandated R...See more
- 2.00 Participation
$0.00
Mandated reporters can participate in this 2-hour web-based online training course at any time, 24/7. Users must complete the course within the course duration which is the current calendar year. Progress is saved at the end of each section, so you can complete it at your own pace. Please be advised that the Office of Children and Family Services now requires all mandated reporters to take a short multiple choice test both before and after the mandated reporter training.
- Weight Management
- 1.00 AMA PRA Category 1 Credit™
$0.00
Obesity currently affects more than 41% of adults in the United States. It is a complex and chronic medical condition that is often associated with reduced quality of life in the absence of appropriate care and the development of diabetes, hypertension, cardiovascular disease, and other comorbidities. Once considered a condition caused by poor eating habits and lack of self-control or will power, obesity is now recognized as a disease that calls for long-term medical management and often requires pharmacotherapeutic intervention for adequate weight control.
- Health Equity
- 0.50 AMA PRA Category 1 Credit™
$0.00
Healthcare disparities disproportionately affect minoritized and low-income groups, contributing to poor health outcomes. Patient-provider distrust, knowledge gaps, and lack of shared decision making contribute to health disparities in these patient groups and influence disease outcomes. It is critical for clinicians to understand the social determinants of health impacting IBD patient care and develop strategies to reduce disparities. In addition, implicit bias significantly affects clinician-patient interaction, as well as diagnosis and treatment decisions.